Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1122380

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1122380

Veterinary Antibiotics Market, by Product Type, by End-use, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

PUBLISHED:
PAGES: 165 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

An antimicrobial can be described as a natural, semi-synthetic, or synthetic substance that kills or inhibits most microorganisms but causes little or no loss to the host. All antibiotics are antimicrobials; however, not all antimicrobials are antibiotics. Antimicrobial products have remarkable food safety benefits for both animals and humans. Veterinary antibiotics can be used in animals and can contribute to the spread of antibiotic resistance in bacteria that can be transmitted to humans; henceforth, it decreases the effectiveness of antimicrobial drugs used to treat human diseases.

There are studies that have shown that an increase in the rate of disease in animals leads to a higher rate of disease in humans. Therefore, livestock traders rely on animal antibiotics to deliver safe food. Antimicrobial and antibiotic treatments for animals are sold to various end-use segments such as dairy market, animal meat market, pet market, livestock market and animal feed market.

Market Dynamics

Increasing adoption of inorganic strategies by key players in market such as acquisition is expected to drive market growth over the forecast period. For instance, in August 2020, Elanco Animal Health Incorporated, a global leader in animal health announced the acquisition of Bayer Animal Health. The companies had signed a definitive agreement to acquire and transaction was completed after fulfillment of the closing conditions, including the receipt of regulatory approvals. This agreement will help in the expansion of Elanco's portfolio of leading global brands and strengthens its innovation capabilities and R&D pipeline.

Key features of the study:

  • This report provides an in-depth analysis of the global veterinary antibiotics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global veterinary antibiotics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Crystal Pharma, Dechra Pharmaceuticals PLC, Huvepharma AD, Eli Lilly Company, Elanco, Merck & Co., Inc., Sanofi S.A., Vetoquinol S.A., Virbac, and Zoetis, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global veterinary antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary antibiotics market

Detailed Segmentation:

  • Global Veterinary Antibiotics Market, By Product Type:
    • Anti-parasitic
    • Anti-bacterial
    • Non-steroidal anti-inflammatory drug
    • Others
  • Global Veterinary Antibiotics Market, By End-use:
    • Dairy Farm
    • Poultry Farm
    • Others
  • Global Veterinary Antibiotics Market, By Region:
    • North America
      • By Country
    • U.S.
    • Canada
    • Latin America
      • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Region/Country
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Bayer AG
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Boehringer Ingelheim GmbH
    • Ceva Sante Animale S.A.
    • Crystal Pharma
    • Dechra Pharmaceuticals PLC
    • Huvepharma AD
    • Eli Lilly Company
    • Merck & Co., Inc.
    • Sanofi S.A.
    • Vetoquinol S.A.
    • Virbac
    • Zoetis, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI2324

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By End-use
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Technology Overview
  • Regulatory Scenario
  • Antibiotics Substitutes
  • Pipeline Analysis
  • PEST Analysis

4. Global Veterinary Antibiotics Market- Impact of Coronavirus (Covid-19) Pandemic

  • Overall Impact
  • Impact on Supply and Demand
  • COVID-19 Impact on the market

5. Global Veterinary Antibiotics Market, By Product Type, 2017 - 2030, (US$ Billion)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Anti-parasitic
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Anti-bacterial
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Non-steroidal anti-inflammatory drug
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)

6. Global Veterinary Antibiotics Market, By End-use, 2017 - 2030, (US$ Billion)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Dairy Farm
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Poultry Farm
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)

7. Global Veterinary Antibiotics Market, By Region, 2017 - 2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2017 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2017 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2017 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2017 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2017 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Billion)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use, 2017 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Billion)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

o

    • Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Boehringer Ingelheim GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Ceva Sante Animale S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Crystal Pharma
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Dechra Pharmaceuticals PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Huvepharma AD
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Eli Lilly Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Elanco
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Sanofi S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Vetoquinol S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Virbac
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • Zoetis, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Section

  • Research Methodology
  • About Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!